North Star Asset Management Inc. bought a new stake in shares of Plexus Corp. (NASDAQ:PLXS – Free Report) in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor bought 2,085 shares of the technology company’s stock, valued at approximately $225,000.
A number of other hedge funds and other institutional investors also recently bought and sold shares of PLXS. SG Americas Securities LLC purchased a new stake in Plexus during the third quarter valued at approximately $1,301,000. Avior Wealth Management LLC purchased a new position in shares of Plexus in the third quarter worth $91,000. Integrated Investment Consultants LLC raised its holdings in shares of Plexus by 3.1% in the third quarter. Integrated Investment Consultants LLC now owns 3,848 shares of the technology company’s stock worth $358,000 after buying an additional 116 shares during the last quarter. Boston Trust Walden Corp raised its holdings in shares of Plexus by 38.0% in the third quarter. Boston Trust Walden Corp now owns 397,882 shares of the technology company’s stock worth $36,995,000 after buying an additional 109,536 shares during the last quarter. Finally, GW Henssler & Associates Ltd. purchased a new position in shares of Plexus in the third quarter worth $204,000. Hedge funds and other institutional investors own 94.45% of the company’s stock.
Insider Activity at Plexus
In related news, CEO Todd P. Kelsey sold 2,000 shares of Plexus stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $94.30, for a total value of $188,600.00. Following the sale, the chief executive officer now owns 121,859 shares of the company’s stock, valued at approximately $11,491,303.70. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. In related news, CEO Todd P. Kelsey sold 2,000 shares of Plexus stock in a transaction on Thursday, February 1st. The shares were sold at an average price of $94.30, for a total value of $188,600.00. Following the sale, the chief executive officer now owns 121,859 shares of the company’s stock, valued at approximately $11,491,303.70. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, CEO Todd P. Kelsey sold 2,500 shares of Plexus stock in a transaction on Monday, February 26th. The stock was sold at an average price of $94.47, for a total transaction of $236,175.00. Following the sale, the chief executive officer now directly owns 125,310 shares in the company, valued at approximately $11,838,035.70. The disclosure for this sale can be found here. In the last quarter, insiders have sold 32,453 shares of company stock valued at $3,112,875. 2.39% of the stock is owned by company insiders.
Plexus Trading Up 1.0 %
Plexus (NASDAQ:PLXS – Get Free Report) last posted its quarterly earnings data on Thursday, January 25th. The technology company reported $1.04 EPS for the quarter, missing analysts’ consensus estimates of $1.05 by ($0.01). Plexus had a net margin of 3.08% and a return on equity of 12.16%. The business had revenue of $982.61 million during the quarter, compared to analysts’ expectations of $982.57 million. During the same quarter last year, the firm earned $1.49 earnings per share. The firm’s quarterly revenue was down 10.2% compared to the same quarter last year. As a group, equities analysts forecast that Plexus Corp. will post 4.25 EPS for the current fiscal year.
Analysts Set New Price Targets
A number of research firms have issued reports on PLXS. Benchmark reaffirmed a “buy” rating and issued a $110.00 price target on shares of Plexus in a report on Wednesday, January 17th. Sidoti lowered shares of Plexus from a “buy” rating to a “neutral” rating and set a $112.00 price target on the stock. in a report on Tuesday, January 9th. TheStreet lowered Plexus from a “b” rating to a “c+” rating in a research note on Tuesday, February 13th. Finally, Needham & Company LLC dropped their target price on Plexus from $110.00 to $107.00 and set a “buy” rating on the stock in a report on Thursday, January 25th. Two investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $109.67.
Get Our Latest Analysis on PLXS
Plexus Company Profile
Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.
Featured Articles
- Five stocks we like better than Plexus
- CD Calculator: Certificate of Deposit Calculator
- Sherwin-William’s Win Over PPG Stock in The Construction Boom
- Ride Out The Recession With These Dividend Kings
- Zscaler’s Potential Upside Continues to Explode
- Why Understanding Call Option Volume is Essential to Successful Options Trading
- 3 A.I. Stocks to Watch Out For Not Named NVIDIA
Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXS – Free Report).
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.